Lobe Sciences Ltd. announced private placement to issue convertible note for gross proceeds of $0.25 million on February 10, 2023. The note has a simple interest of 11% per annum. The note is expected to mature on January 31, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 CAD | 0.00% | +33.33% | -20.00% |
Feb. 15 | Lobe Sciences Ltd. Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
2023 | Lobe Sciences Provides Update on L-130 Clinical Program | MT |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.00% | 2.41M | |
+35.04% | 5.92B | |
-15.13% | 4.51B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
-7.89% | 1.68B | |
+0.09% | 1.65B | |
-12.97% | 1.53B |
- Stock Market
- Equities
- LOBE Stock
- News Lobe Sciences Ltd.
- Lobe Sciences Ltd. announced that it expects to receive $0.25 million in funding